Results for tag: "Angelman Syndrome Drugs"

Angelman Syndrome Drugs are a type of Central Nervous System (CNS) Drugs used to treat Angelman Syndrome, a rare neurological disorder. These drugs are designed to reduce the symptoms of the disorder, which can include developmental delays, seizures, and difficulty with movement and balance. The Angelman Syndrome Drugs market is relatively small, but is growing as more treatments become available. The most common Angelman Syndrome Drugs are anticonvulsants, which are used to control seizures. Other drugs used to treat the disorder include stimulants, antipsychotics, and antidepressants. These drugs are typically prescribed in combination with behavioral therapies and other interventions. The Angelman Syndrome Drugs market is highly competitive, with many companies offering treatments for the disorder. Some of the major players in the market include AbbVie, Biogen, Eisai, Lundbeck, and Otsuka Pharmaceuticals. Show Less Read more